ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Oxygen delivery and consumption

Oxygen delivery and consumption
Literature review current through: Jan 2024.
This topic last updated: Dec 08, 2023.

INTRODUCTION — Inspired oxygen from the environment moves across the alveolar-capillary membrane into the blood. Most of the oxygen binds to hemoglobin in red blood cells, although a small amount dissolves into the plasma. The oxygen is then transported from the lungs to the peripheral tissues, where it is removed from the blood and used to fuel aerobic cellular metabolism. This process can be conceptualized as three steps: oxygenation, oxygen delivery, and oxygen consumption. In this topic review, oxygen delivery and consumption are reviewed. Oxygenation is discussed separately. (See "Measures of oxygenation and mechanisms of hypoxemia".)

DEFINITIONS

Oxygen content — The arterial oxygen content (CaO2) is the amount of oxygen bound to hemoglobin plus the amount of oxygen dissolved in arterial blood:

CaO2 (mL O2/dL) = (1.34 x hemoglobin concentration x SaO2) + (0.0031 x PaO2)

where SaO2 is the arterial oxyhemoglobin saturation and PaO2 is the arterial oxygen tension. In dyshemoglobinemias, the oxygen content is calculated with the same equation, although the saturations (and therefore the oxygen content) will be different for a specific PaO2 [1]. Normal CaO2 is approximately 20 mL O2/dL.

Similarly, the mixed venous blood oxygen content (CvO2) is the amount of oxygen bound to hemoglobin plus the amount of oxygen dissolved in mixed venous blood:

CvO2 (mL O2/dL) = (1.34 x hemoglobin concentration x SvO2) + (0.0031 x PvO2)

where SvO2 is the mixed venous oxyhemoglobin saturation and PvO2 is the mixed venous oxygen tension. Normal CvO2 is approximately 15 mL O2/dL. Mixed venous blood is drawn from the right atrium. Peripheral venous blood should not be substituted because it tends to overestimate venous oxygen content.

Oxygen delivery — Oxygen delivery (DO2) is the rate at which oxygen is transported from the lungs to the microcirculation:

DO2 (mL/min) = Q x CaO2

where Q is the cardiac output. Normal DO2 is approximately 1000 mL/min. Normal DO2 is approximately 500 mL/min/m2 if cardiac index is substituted for cardiac output.

Realize, cardiac output can be measured by thermodilution using a pulmonary artery catheter, or calculated using the Fick equation:

Q (L/min) = Oxygen consumption ÷ (10 x arteriovenous oxygen difference)

where oxygen consumption is either measured by respirometry (discussed below) or estimated using a nomogram, and the arteriovenous (AV) oxygen difference is calculated:

AV oxygen difference (mL O2/dL) = CaO2 - CvO2

Oxygen consumption — Oxygen consumption (VO2) is the rate at which oxygen is removed from the blood for use by the tissues. It can be measured directly or calculated. Both approaches assume that all unused oxygen passes from the arterial to the venous circulation.

Direct measurement of VO2 is performed by respirometry. During respirometry, the patient breathes through a chamber that receives continuous air flow. Measurement of the oxygen depleted from the chamber, as well as the carbon dioxide and water vapor produced in the chamber, is used to determine VO2. Respirometry can be used in mechanically ventilated patients, but the accuracy of direct measurement of VO2 diminishes at high oxygen concentrations (eg, >80 percent) [2-7]. Normal VO2 in a conscious, resting person is approximately 250 mL O2/min.

Calculation of VO2 can be performed by rearranging the Fick equation:

VO2 (mL O2/min) = Q x (CaO2 - CvO2)

When calculating VO2, cardiac output should be measured and not calculated from the Fick equation or a mathematical coupling error may be introduced.

Oxygen extraction — Oxygen extraction is the slope of the relationship between oxygen delivery (DO2) and oxygen consumption (VO2). It is most commonly expressed as the oxygen extraction ratio, which is the proportion of arterial oxygen that is removed from the blood as it passes through the microcirculation:

O2 Extraction Ratio = (CaO2 - CvO2)/CaO2

Normal O2 extraction ratios range from 0.25 to 0.3.

NORMAL PHYSIOLOGY — Under normal circumstances:

Oxygen consumption (VO2) is proportional to oxygen delivery (DO2) and oxygen extraction

DO2 and oxygen extraction are inversely proportional to one another

At rest, VO2 remains constant over a wide range of oxygen delivery (DO2) because changes in DO2 are balanced by reciprocal changes in oxygen extraction (figure 1). VO2 decreases if DO2 declines to such a degree that it cannot be balanced by increasing oxygen extraction. The threshold value of DO2 below which VO2 will fall is called the "critical DO2" (figure 2).

When metabolic demand increases (eg, exercise, pregnancy), VO2 also increases because more oxygen is required to maintain aerobic cellular metabolism. This is normally achieved by increasing both DO2 and oxygen extraction [8,9]. VO2 is disproportionately impacted by the increased oxygen extraction, with the increased DO2 contributing little [10]. Enhanced extraction of oxygen is probably mediated at the capillary level [8]. Studies suggest dysregulation of peripheral extraction may play an important role in limiting exercise capacity in some disorders such as heart failure with preserved ejection fraction [11]

ABNORMALITIES OF OXYGEN DELIVERY AND DEMAND — Decreased oxygen delivery or increased metabolic demand are common sequelae of medical illness.

Decreased oxygen delivery — Oxygen delivery (DO2) will decrease if cardiac output falls or arterial oxygen content (CaO2) declines.

Cardiac output can decrease due to cardiac disease or hypovolemia.

CaO2 can decrease due to anemia or poor oxygenation. The latter can be caused by lung disease (eg, ventilation-perfusion mismatch, diffusion limitation), a right-to-left shunt, diminished inspired oxygen, or hypoventilation. (See "Measures of oxygenation and mechanisms of hypoxemia".)

In the setting of diminished DO2, maintenance of a normal oxygen consumption (VO2) can be accomplished by a compensatory increase in oxygen extraction [12]. If increased oxygen extraction is insufficient to maintain VO2, cardiac output will increase in an effort to improve DO2. VO2 will fall if these actions are insufficient and DO2 is below the critical DO2 [13].

Increased metabolic demand — Metabolic demand is elevated in critically ill patients (eg, acute respiratory distress syndrome, sepsis, or septic shock) [3,6,14-21]. VO2 increases because more oxygen is required to maintain aerobic cellular metabolism. In critically ill patients, VO2 elevation may be disproportionately accomplished by increasing the DO2. This is different from healthy individuals in whom VO2 elevation is disproportionately accomplished by increasing the oxygen extraction, with DO2 contributing little [10]. Whether such a difference exists between healthy and critically ill individuals is controversial:

Proponents believe that VO2 is disproportionately affected by DO2 because oxygen extraction is impaired during critical illness. Supporting this hypothesis, lactic acidosis is often present despite increased DO2 [22,23]. In other words, anaerobic metabolism is required despite an increased supply of oxygen. Ineffective oxygen extraction may be due to poor oxygen uptake or poor utilization by the cells [15].

Opponents argue that both VO2 and DO2 were calculated in most of the studies that suggest that DO2 has a disproportionate impact on VO2 during critical illness [24]. This could introduce mathematical coupling errors, which would falsely increase the strength of the relationship between VO2 and DO2. In addition, VO2 was not disproportionately affected by DO2 in the few studies that directly measured VO2 [3,25-28].

We believe that the relationship between DO2 and VO2 in critically ill patients is similar to that in healthy patients during increased metabolic demand (eg, exercise, pregnancy). In other words, we believe that increased oxygen extraction, and not increased DO2, has the greatest impact on increasing the VO2 in critically ill patients. We base this belief on the following:

Numerous studies have evaluated the impact of augmenting DO2 on VO2 with conflicting results [3,7,9,25-44]. Methods of augmenting DO2 have included inotropic agents, saline loading, and vasodilators to improve cardiac output, as well as red blood cell transfusions to increase arterial oxygen content (CaO2). Regardless of the intervention, DO2 and VO2 were strongly correlated when VO2 and DO2 were both calculated, but not when VO2 was directly measured.

A few studies have evaluated the impact of augmenting DO2 and patient-centered outcomes, such as survival, organ failure, length of ICU stay, and length of hospitalization [35,37-39,45-51]. While some of the studies found an improvement in morbidity or mortality, others found no effect or potential harm. Those that demonstrated improvement had significant methodologic problems, such as baseline differences between the treatment and control groups, and failure to use an intention-to-treat analysis.

Taken together, we believe there are insufficient data to warrant the routine augmentation of DO2 in critically ill patients if there is no evidence of ongoing tissue hypoxia.

SUMMARY AND RECOMMENDATIONS

Definitions – Inspired oxygen from the environment moves across the alveolar-capillary membrane into the blood and is then transported to the peripheral tissues. There, it is removed from the blood and used to fuel aerobic cellular metabolism. This process can be conceptualized as three steps: oxygenation, oxygen delivery, and oxygen consumption. (See 'Introduction' above.)

The arterial oxygen content (CaO2) is the amount of oxygen bound to hemoglobin plus the amount of oxygen dissolved in arterial blood, while the mixed venous blood oxygen content (CvO2) is the amount of oxygen bound to hemoglobin plus the amount of oxygen dissolved in mixed venous blood. (See 'Oxygen content' above.)

Oxygen delivery (DO2) is the rate at which oxygen is transported from the lungs to the microcirculation, oxygen consumption (VO2) is the rate at which oxygen is removed from the blood for use by the tissues, and oxygen extraction is the proportion of arterial oxygen that is removed from the blood as it passes through the microcirculation. (See 'Oxygen delivery' above and 'Oxygen consumption' above and 'Oxygen extraction' above.)

Normal physiology – VO2 normally remains constant over a wide range of DO2 because changes in DO2 are balanced by reciprocal changes in oxygen extraction. VO2 will decrease only if DO2 declines to such a degree that it cannot be balanced by increasing oxygen extraction. VO2 increases when metabolic demand increases (eg, exercise, pregnancy). This is disproportionately accomplished by increasing the oxygen extraction, with DO2 contributing little(See 'Normal physiology' above.)

Abnormalities of oxygen delivery and consumption – Decreased oxygen delivery or increased metabolic demand are common sequelae of medical illness.

When DO2 is decreased (eg, heart failure), a compensatory increase in oxygen extraction may allow VO2 to remain normal. If increased oxygen extraction is insufficient to maintain VO2, cardiac output will increase in an effort to improve DO2. VO2 will fall if these compensatory mechanisms are inadequate. (See 'Decreased oxygen delivery' above.)

When metabolic demand increases (eg, sepsis), VO2 also increases. This may be disproportionately accomplished by increasing the DO2, rather than enhancing the oxygen extraction. In critically ill patients in whom there is no evidence of ongoing tissue hypoxia, we do not routinely augment DO2. (See 'Increased metabolic demand' above.)

  1. Needleman JP, Setty BN, Varlotta L, et al. Measurement of hemoglobin saturation by oxygen in children and adolescents with sickle cell disease. Pediatr Pulmonol 1999; 28:423.
  2. Feenstra BW, Holland WP, van Lanschot JJ, Bruining HA. Design and validation of an automatic metabolic monitor. Intensive Care Med 1985; 11:95.
  3. Vermeij CG, Feenstra BW, Adrichem WJ, Bruining HA. Independent oxygen uptake and oxygen delivery in septic and postoperative patients. Chest 1991; 99:1438.
  4. Mira JP, Fabre JE, Baigorri F, et al. Lack of oxygen supply dependency in patients with severe sepsis. A study of oxygen delivery increased by military antishock trouser and dobutamine. Chest 1994; 106:1524.
  5. Shepherd AP, Granger HJ, Smith EE, Guyton AC. Local control of tissue oxygen delivery and its contribution to the regulation of cardiac output. Am J Physiol 1973; 225:747.
  6. Dantzker DR, Foresman B, Gutierrez G. Oxygen supply and utilization relationships. A reevaluation. Am Rev Respir Dis 1991; 143:675.
  7. Dantzker D. Oxygen delivery and utilization in sepsis. Crit Care Clin 1989; 5:81.
  8. Cain SM. Acute lung injury. Assessment of tissue oxygenation. Crit Care Clin 1986; 2:537.
  9. Kruse JA, Haupt MT, Puri VK, Carlson RW. Lactate levels as predictors of the relationship between oxygen delivery and consumption in ARDS. Chest 1990; 98:959.
  10. Chioléro R, Flatt JP, Revelly JP, Jéquier E. Effects of catecholamines on oxygen consumption and oxygen delivery in critically ill patients. Chest 1991; 100:1676.
  11. Dhakal BP, Malhotra R, Murphy RM, et al. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail 2015; 8:286.
  12. Cain SM. Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol Respir Environ Exerc Physiol 1977; 42:228.
  13. Shibutani K, Komatsu T, Kubal K, et al. Critical level of oxygen delivery in anesthetized man. Crit Care Med 1983; 11:640.
  14. Wysocki M, Besbes M, Roupie E, Brun-Buisson C. Modification of oxygen extraction ratio by change in oxygen transport in septic shock. Chest 1992; 102:221.
  15. Silverman HJ. Lack of a relationship between induced changes in oxygen consumption and changes in lactate levels. Chest 1991; 100:1012.
  16. Annat G, Viale JP, Percival C, et al. Oxygen delivery and uptake in the adult respiratory distress syndrome. Lack of relationship when measured independently in patients with normal blood lactate concentrations. Am Rev Respir Dis 1986; 133:999.
  17. Shoemaker WC, Appel PL, Kram HB. Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest 1992; 102:208.
  18. Vermeij CG, Feenstra BW, Bruining HA. Oxygen delivery and oxygen uptake in postoperative and septic patients. Chest 1990; 98:415.
  19. Russell JA, Ronco JJ, Lockhat D, et al. Oxygen delivery and consumption and ventricular preload are greater in survivors than in nonsurvivors of the adult respiratory distress syndrome. Am Rev Respir Dis 1990; 141:659.
  20. Danek SJ, Lynch JP, Weg JG, Dantzker DR. The dependence of oxygen uptake on oxygen delivery in the adult respiratory distress syndrome. Am Rev Respir Dis 1980; 122:387.
  21. Mohsenifar Z, Goldbach P, Tashkin DP, Campisi DJ. Relationship between O2 delivery and O2 consumption in the adult respiratory distress syndrome. Chest 1983; 84:267.
  22. Kariman K, Burns SR. Regulation of tissue oxygen extraction is disturbed in adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132:109.
  23. Ronco JJ, Montaner JS, Fenwick JC, et al. Pathologic dependence of oxygen consumption on oxygen delivery in acute respiratory failure secondary to AIDS-related Pneumocystis carinii pneumonia. Chest 1990; 98:1463.
  24. Russell JA, Phang PT. The oxygen delivery/consumption controversy. Approaches to management of the critically ill. Am J Respir Crit Care Med 1994; 149:533.
  25. Ronco JJ, Phang PT, Walley KR, et al. Oxygen consumption is independent of changes in oxygen delivery in severe adult respiratory distress syndrome. Am Rev Respir Dis 1991; 143:1267.
  26. Villar J, Slutsky AS, Hew E, Aberman A. Oxygen transport and oxygen consumption in critically ill patients. Chest 1990; 98:687.
  27. Weissman C, Kemper M. The oxygen uptake-oxygen delivery relationship during ICU interventions. Chest 1991; 99:430.
  28. Boyd O, Grounds M, Bennett D. The dependency of oxygen consumption on oxygen delivery in critically ill postoperative patients is mimicked by variations in sedation. Chest 1992; 101:1619.
  29. Majerus TC, Chodoff P, Borel CO. Dopamine and dobutamine in septic shock. A comparison. Arch Int Physiol Biochim 1984; 92:S65.
  30. Gilbert EM, Haupt MT, Mandanas RY, et al. The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis 1986; 134:873.
  31. Shoemaker WC, Appel PL, Kram HB. Hemodynamic and oxygen transport effects of dobutamine in critically ill general surgical patients. Crit Care Med 1986; 14:1032.
  32. Shoemaker WC, Appel PL, Kram HB, et al. Comparison of hemodynamic and oxygen transport effects of dopamine and dobutamine in critically ill surgical patients. Chest 1989; 96:120.
  33. Vincent JL, Roman A, Kahn RJ. Dobutamine administration in septic shock: addition to a standard protocol. Crit Care Med 1990; 18:689.
  34. Vincent JL, Roman A, De Backer D, Kahn RJ. Oxygen uptake/supply dependency. Effects of short-term dobutamine infusion. Am Rev Respir Dis 1990; 142:2.
  35. Lobo SM, Salgado PF, Castillo VG, et al. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 2000; 28:3396.
  36. Ronco JJ, Fenwick JC, Wiggs BR, et al. Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am Rev Respir Dis 1993; 147:25.
  37. Hayes MA, Timmins AC, Yau EH, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717.
  38. Alía I, Esteban A, Gordo F, et al. A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest 1999; 115:453.
  39. Tuchschmidt J, Fried J, Astiz M, Rackow E. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992; 102:216.
  40. Bollaert PE, Bauer P, Audibert G, et al. Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 1990; 98:949.
  41. Kaufman BS, Rackow EC, Falk JL. The relationship between oxygen delivery and consumption during fluid resuscitation of hypovolemic and septic shock. Chest 1984; 85:336.
  42. Bihari D, Smithies M, Gimson A, Tinker J. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 1987; 317:397.
  43. Pittet JF, Lacroix JS, Gunning K, et al. Prostacyclin but not phentolamine increases oxygen consumption and skin microvascular blood flow in patients with sepsis and respiratory failure. Chest 1990; 98:1467.
  44. Silverman HJ, Slotman G, Bone RC, et al. Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group. Chest 1990; 98:405.
  45. Shoemaker WC, Appel PL, Kram HB, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94:1176.
  46. Edwards JD, Brown GC, Nightingale P, et al. Use of survivors' cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med 1989; 17:1098.
  47. Yu M, Levy MM, Smith P, et al. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med 1993; 21:830.
  48. Bishop MH, Shoemaker WC, Appel PL, et al. Prospective, randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. J Trauma 1995; 38:780.
  49. Hinds C, Watson D. Manipulating hemodynamics and oxygen transport in critically ill patients. N Engl J Med 1995; 333:1074.
  50. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333:1025.
  51. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409.
Topic 1623 Version 17.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟